← Back to Clinical Trials
Recruiting NCT06948162

NCT06948162 Exploration of the Utility of Dental-dedicated MRI for Dentistry

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06948162
Status Recruiting
Phase
Sponsor Donald Nixdorf
Condition Dental Crowding
Study Type OBSERVATIONAL
Enrollment 300 participants
Start Date 2025-03-17
Primary Completion 2028-01-01

Trial Parameters

Condition Dental Crowding
Sponsor Donald Nixdorf
Study Type OBSERVATIONAL
Phase N/A
Enrollment 300
Sex ALL
Min Age 18 Years
Max Age N/A
Start Date 2025-03-17
Completion 2028-01-01
Interventions
dental-dedicated MRI (ddMRI)

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

This description observational research is comparative in design, that is comparing existing standard clinical dental images, not obtained in this study, to test (i.e., ddMRI) images. The standard clinical dental images consist of radiographs, such as bitewings, periapical, panoramic, cone-beam CT, and medical CT, as well medical MRIs of the temporomandibular joints (TMJ).The conceptualization of research questions, study designing, and interpretation of imaging data has and will involve content expertise in all ddMRI research.

Eligibility Criteria

Inclusion Criteria: 1. Patient Age: 18 years old or older 2. Receiving imaging for routine dental care 3. Does not have a serious medical condition 4. Is not pregnant or is not potentially pregnant 5. Is willing and able to give consent in English 6. Has the ability to manage their own calendar and schedule appointments 7. Willing to have a separate 2-hour appointment to have an MRI Exclusion Criteria: 1. Unable to consent to participant in English 2. Serious health condition, which includes but not limited to renal failure/on dialysis, unstable heart disease (uncontrolled arrhythmia, cardiomyopathy and/or unable to lay flat, within 1 month of cardiac catheterization or myocardial infarction), unstable cerebral vascular disease (within 1 month of stroke and/or stent placement), diabetes (type I or II) not controlled by medication or diet, uncontrolled seizures, uncontrolled hyperthyroidism, non-allergic bronchospasm (chronic obstructive pulmonary disease and emphysema), uncontrolled mo

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology